Close

BIO 2000 Opening Plenary Speech / Boston

We meet here in Boston at a truly remarkable moment in the relatively short but dramatic history of the biotechnology industry.

BIO SUPPORTS NEW GUIDELINES TO ENSURE PATIENT CONFIDENCE IN GENE THERAPY TREATMENT

(Michael J. Werner, Director of Federal Government Relations/Bioethics Counsel for the Biotechnology Industry Organization (BIO), issued the following statement today regarding the Dept. of Health...

BIO Selects DoubleTwist To Build Web Portal For Life Sciences Researchers, Companies

WASHINGTON, D.C. and OAKLAND, Calif., May 17, 2000 The Biotechnology Industry Organization (BIO) and DoubleTwist Inc. today announced they signed a letter of intent to collaborate on building a...

BIO CEOs, Lawmakers Talk Policy At Legislative Day

WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150 biotech executives expected to...

BIO Says Maine Price Control Law Will Hurt Patients, Stifle Biotech Innovation

WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine law that ultimately will result in...

BIO Supportive of FDA Announcement on Biotech Policies

(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s announcement regarding the agency’s...

XENOTRANSPLANTATION: The Benefits and Risks of Special Organ Transplantation

A Position Paper fromThe Biotechnology Industry Organization

Executive Summary

1. Human organ transplantation faces a significant challenge because the need for this procedure far exceeds the...

Testimony on the Proposed Rule on Confidentiality of Patient Records

Regarding the Proposed Rule on Confidentiality of Patient Records Could Impede Research before the Senate Health, Education, Labor and Pensions Committee.

BIO Testifies Proposed Rule On Confidentiality Of Patient Records Could Impede Research

WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton administration’s proposed rule for...

Gorton Bill Will Result In Price Controls, Hurting Seniors, Not Helping Them

WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to U.S. Sen. Slade Gorton’s (R-Wash.)...